Blueprint Medicines Corporation (BIT:1BPMC)

Blueprint Medicines Market Cap

Blueprint Medicines is not actively traded anymore. When Blueprint Medicines last traded, it had a market cap or net worth of $7.23 billion.

• Market Cap: 7.23B
• Enterprise Value: 7.07B
• Revenue: 520.07M
• Ranking: n/a
• PE Ratio: n/a
• Stock Price: €105.10

Market Cap Chart

Since April 30, 2015, Blueprint Medicines's market cap has increased from 435.41M to 7.23B, an increase of 1,560.82%. That is a compound annual growth rate of 31.64%.

Market Cap History

Date	Market Cap	% Change
Jul 17, 2025	7.23B	35.12%
Dec 31, 2024	5.35B	5.50%
Dec 29, 2023	5.07B	106.83%
Dec 30, 2022	2.45B	-55.74%
Dec 31, 2021	5.54B	8.45%
Dec 31, 2020	5.11B	45.47%